SABS icon

SAB Biotherapeutics

42 hedge funds and large institutions have $24.5M invested in SAB Biotherapeutics in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 5 closing their positions.

Holders
42
Holders Change
+8
Holders Change %
+23.53%
% of All Funds
0.62%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
7
Reduced
3
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
TRCT
26
Tower Research Capital (TRC)
New York
$10.5K 15,235 +295 +2%
NFG
27
Nadler Financial Group
Illinois
$9.45K 13,750
Commonwealth Equity Services
28
Commonwealth Equity Services
Massachusetts
$9K 12,823 +12,823 New
1SB
29
1ST Source Bank
Indiana
$6.88K 10,000
Baird Financial Group
30
Baird Financial Group
Wisconsin
$6.88K 10,000
ECM
31
Elgethun Capital Management
South Dakota
$6.47K 5,435 -4,500 -45%
SWC
32
Spectrum Wealth Counsel
Indiana
$3.46K 5,030 +5,030 New
LA
33
LM Advisors
California
$2.49K 3,620 +3,620 New
GI
34
GS Investments
Minnesota
$1.38K 2,000
JPMorgan Chase & Co
35
JPMorgan Chase & Co
New York
$654 951 +24 +3%
UBS Group
36
UBS Group
Switzerland
$344 500 +500 New
Fidelity Investments
37
Fidelity Investments
Massachusetts
$236 343
Wells Fargo
38
Wells Fargo
California
$202 294 +26 +10%
NA
39
NewEdge Advisors
Louisiana
$100 145
Qube Research & Technologies (QRT)
40
Qube Research & Technologies (QRT)
United Kingdom
$47 69
Bank of America
41
Bank of America
North Carolina
$38 54 +54 New
HighTower Advisors
42
HighTower Advisors
Illinois
-73,470 Closed
LP
43
LGL Partners
Pennsylvania
-23,000 Closed
BCM
44
Brookstone Capital Management
Illinois
-21,755 Closed
SFC
45
Strategic Financial Concepts
Texas
-15,027 Closed
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$0 68 -5,026 -99%
HI
47
Harbour Investments
Wisconsin
-500 Closed
CFGS
48
Concourse Financial Group Securities
Alabama